Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Sciences | 1 | 2017 | 1 | 0.550 |
Why?
|
| Behavioral Research | 1 | 2017 | 2 | 0.550 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 22 | 0.550 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 1 | 0.520 |
Why?
|
| Chromosome Duplication | 1 | 2016 | 1 | 0.520 |
Why?
|
| Dendrites | 1 | 2016 | 8 | 0.520 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 594 | 0.510 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 35 | 0.500 |
Why?
|
| Culture | 1 | 2013 | 22 | 0.420 |
Why?
|
| Neurosciences | 1 | 2013 | 9 | 0.420 |
Why?
|
| Health Status Disparities | 1 | 2013 | 72 | 0.400 |
Why?
|
| Mental Health | 1 | 2013 | 102 | 0.380 |
Why?
|
| Anemia, Sickle Cell | 2 | 2021 | 13 | 0.330 |
Why?
|
| Cultural Evolution | 1 | 2009 | 1 | 0.330 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 12 | 0.320 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 6 | 0.320 |
Why?
|
| Social Values | 1 | 2009 | 10 | 0.320 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 142 | 0.250 |
Why?
|
| Schizophrenia | 2 | 2016 | 50 | 0.240 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 131 | 0.230 |
Why?
|
| Life Cycle Stages | 1 | 2022 | 5 | 0.200 |
Why?
|
| Depressive Disorder, Major | 2 | 2014 | 96 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 35 | 0.190 |
Why?
|
| Leg Ulcer | 1 | 2021 | 4 | 0.180 |
Why?
|
| Brain | 2 | 2019 | 1422 | 0.170 |
Why?
|
| Alzheimer Disease | 3 | 2019 | 1812 | 0.160 |
Why?
|
| Motor Activity | 3 | 2019 | 292 | 0.160 |
Why?
|
| Microbiota | 1 | 2021 | 98 | 0.160 |
Why?
|
| Humans | 11 | 2021 | 25950 | 0.160 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 21 | 0.160 |
Why?
|
| Histones | 1 | 2019 | 34 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Gene Editing | 1 | 2018 | 7 | 0.150 |
Why?
|
| Animals | 6 | 2022 | 3575 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 83 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 12 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2017 | 18 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 215 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 2 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 7 | 0.130 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 11 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 22 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 28 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 448 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2016 | 40 | 0.120 |
Why?
|
| Phenotype | 1 | 2016 | 289 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2016 | 511 | 0.120 |
Why?
|
| Cognition | 2 | 2019 | 1214 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 7 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 22 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 15 | 0.110 |
Why?
|
| Genome, Human | 1 | 2013 | 41 | 0.100 |
Why?
|
| Forecasting | 1 | 2013 | 90 | 0.100 |
Why?
|
| Social Environment | 1 | 2013 | 64 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2013 | 54 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 280 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2012 | 32 | 0.100 |
Why?
|
| Stress, Psychological | 2 | 2012 | 225 | 0.090 |
Why?
|
| United States | 1 | 2017 | 1935 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 944 | 0.090 |
Why?
|
| Amygdala | 1 | 2010 | 40 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2009 | 52 | 0.080 |
Why?
|
| Mood Disorders | 1 | 2009 | 25 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2010 | 171 | 0.080 |
Why?
|
| Demography | 1 | 2009 | 73 | 0.080 |
Why?
|
| Hippocampus | 1 | 2010 | 250 | 0.070 |
Why?
|
| Anxiety | 1 | 2009 | 149 | 0.070 |
Why?
|
| Prevalence | 1 | 2009 | 438 | 0.070 |
Why?
|
| Rats | 3 | 2014 | 624 | 0.070 |
Why?
|
| Amphetamine | 1 | 2002 | 6 | 0.050 |
Why?
|
| Male | 5 | 2019 | 14087 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2002 | 30 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 40 | 0.050 |
Why?
|
| Aged | 3 | 2019 | 8480 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1044 | 0.050 |
Why?
|
| Rats, Inbred WKY | 2 | 2012 | 2 | 0.050 |
Why?
|
| Rats, Inbred F344 | 2 | 2012 | 31 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 4409 | 0.040 |
Why?
|
| Female | 4 | 2019 | 14422 | 0.040 |
Why?
|
| Wound Healing | 1 | 2021 | 158 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 16 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 38 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 9 | 0.040 |
Why?
|
| Attitude | 1 | 2018 | 32 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 74 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 116 | 0.040 |
Why?
|
| Gene Expression | 1 | 2019 | 186 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 243 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 282 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 820 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 152 | 0.040 |
Why?
|
| Parents | 1 | 2018 | 109 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2014 | 447 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 909 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 1094 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1269 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 1429 | 0.030 |
Why?
|
| Neuropil | 1 | 2014 | 1 | 0.030 |
Why?
|
| Siblings | 1 | 2014 | 13 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 25 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 29 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1745 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 303 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 216 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 2183 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 550 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 1 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 37 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 113 | 0.020 |
Why?
|
| Child Abuse | 1 | 2012 | 31 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 87 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 72 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 319 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 19 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 2010 | 10 | 0.020 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2010 | 4 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 168 | 0.020 |
Why?
|
| Swimming | 1 | 2010 | 8 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 393 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 58 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 458 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 90 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 122 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 110 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 2123 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 1984 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Prazosin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2002 | 2 | 0.010 |
Why?
|
| Quinpirole | 1 | 2002 | 3 | 0.010 |
Why?
|
| Benzazepines | 1 | 2002 | 4 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2002 | 13 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 46 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 7658 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 309 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2002 | 128 | 0.010 |
Why?
|